Xeris Biopharma Holdings XERS
NASDAQ XERS
$16.52 +0.69 (+4.36%)
At close: Nov 11, 2026 · 4:00 PM EST

Xeris Biopharma Holdings (XERS) Total Debt (2020 - 2026)

Updated

Xeris Biopharma Holdings (XERS) posted Total Debt of $252.59 million for Q2 2026, up 15.5% from $218.63 million a year earlier and up 14.2% from the prior quarter.

Analysis

Xeris Biopharma Holdings (XERS) Total Debt (2020 - 2026) Analysis & Trends

At the end of FY2025, Xeris Biopharma Holdings' Total Debt came in at $220.34 million, down 5.1% from FY2024.

  • Annual Total Debt shows a five-year compound annual growth rate of 20.4% (FY2020 to FY2025).
  • In prior years, Xeris Biopharma Holdings' Total Debt was $232.11 million in FY2024 (+21.6%), $190.93 million in FY2023 (+2.1%), $187.08 million in FY2022 (+112.4%) and $88.07 million in FY2021 (+1.2%).
  • The Q2 2026 figure stands as the highest quarterly Total Debt in data going back to Q4 2020.
  • On a year-over-year basis, Total Debt increased in four of the last eight quarters, with growth averaging 4.8%.
  • The strongest year-over-year quarter for Total Debt in the past five years was Q4 2022, with growth of 112.4%; the weakest was Q2 2025, with a decline of 5.1%.
  • According to Business Quant data, Total Debt for the three prior quarters was $221.22 million (Q1 2026), $220.34 million (Q4 2025) and $219.47 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 49.50 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 44.65 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 80.90 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 53.78 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -6.68 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 54.01 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 26.23 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 62.67 Bn
10 Xeris Biopharma Holdings 2.89 Bn 2.41 Bn 94.80 Mn 189.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 189.71 Mn
Jun 30, 2026 252.59 Mn
Mar 31, 2026 221.22 Mn
Dec 31, 2025 220.34 Mn
Sep 30, 2025 219.47 Mn
Jun 30, 2025 218.63 Mn
Mar 31, 2025 229.76 Mn
Dec 31, 2024 232.11 Mn
Sep 30, 2024 216.23 Mn
Jun 30, 2024 230.48 Mn
Mar 31, 2024 229.67 Mn
Dec 31, 2023 190.93 Mn
Sep 30, 2023 190.42 Mn
Jun 30, 2023 188.18 Mn
Mar 31, 2023 187.62 Mn
Dec 31, 2022 187.08 Mn
Sep 30, 2022 138.51 Mn
Jun 30, 2022 138.07 Mn
Mar 31, 2022 137.64 Mn
Dec 31, 2021 88.07 Mn
API Access

Xeris Biopharma Holdings Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=XERS&period=max&api_key=YOUR_API_KEY